Areva Pharmaceuticals Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 2 mL recall — FDA D-0270-2021
CGMP Deviations: based on a Warning Letter received by the manufacturer of the recalled product for inadequate out-of specification investigations, complaint and the investigation…